Suppr超能文献

高架十字迷宫试验中的恐惧增强取决于应激源的可控性和恐惧条件作用。

Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning.

作者信息

Korte S M, De Boer S F, Bohus B

机构信息

Department of Animal Physiology, University of Groningen, The Netherlands.

出版信息

Stress. 1999 Aug;3(1):27-40. doi: 10.3109/10253899909001110.

Abstract

The purpose of the study was to determine which stressor qualities (escapable vs. inescapable stress and unconditioned vs. conditioned stress) can potentiate fear in the elevated plus-maze. While inescapable stress potentiated fear, escapable stress did not, but escapable stress increased the locomotor activity (closed arm entries). Inescapable stress only potentiated fear when re-exposure to the former shock compartment, 24 h after footshock and without further footshock, took place just before to 90 min before testing in the elevated plus-maze. We conclude that fear-potentiation in the plus-maze depends on stressor controllability and contextual conditioning. Fear-potentiation was reduced by the anxiolytic diazepam (0.5, 1.0 and 2.0 mg/kg, s.c.) and was further enhanced by the anxiogenic DMCM (1.0 mg/kg, s.c). The fear-potentiated plus-maze test may be a valuable tool in the search for novel anxiolytics and in the study of the neurobiology of fear-potentiation, fear conditioning and generalization of fear.

摘要

本研究的目的是确定哪些应激源特质(可逃避应激与不可逃避应激以及非条件应激与条件应激)会增强高架十字迷宫中的恐惧。不可逃避应激会增强恐惧,而可逃避应激则不会,但可逃避应激会增加运动活动(进入封闭臂的次数)。不可逃避应激仅在足底电击后24小时且无进一步电击的情况下,在高架十字迷宫测试前90分钟内重新暴露于先前的电击隔室时才会增强恐惧。我们得出结论,十字迷宫中的恐惧增强取决于应激源的可控性和情境条件作用。抗焦虑药地西泮(0.5、1.0和2.0mg/kg,皮下注射)可降低恐惧增强,而致焦虑剂DMCM(1.0mg/kg,皮下注射)可进一步增强恐惧增强。恐惧增强的高架十字迷宫测试可能是寻找新型抗焦虑药以及研究恐惧增强、恐惧条件作用和恐惧泛化神经生物学的有价值工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验